Review ArticleReview Article
Open Access

Recent insight into potential acute respiratory distress syndrome

Zulkifli Amin and Fitriana N. Rahmawati
Saudi Medical Journal April 2017, 38 (4) 344-349; DOI: https://doi.org/10.15537/smj.2017.4.15843

References

  1. ↵
    1. Strimbu K,
    2. Tavel JA
    (2010) What are Biomarkers? Curr Opin HIV AIDS 5:463–466.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Sigurdsson M,
    2. Sigvaldason K,
    3. Gunnarsson T,
    4. Moller A,
    5. Sigurdsson G
    (2013) Acute respiratory distress syndrome: nationwide changes in incidence, treatment and mortality over 23 years. Acta Anaesthesiol Scand 57:37–45.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Bellani G,
    2. Laffey JG,
    3. Pham T,
    4. Fan E,
    5. Brochard L,
    6. Esteban A,
    7. et al.
    (2016) Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315:788–800.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Walkey AJ,
    2. Summer R,
    3. Ho V,
    4. Alkana P
    (2012) Acute respiratory distress syndrome: epidemiology and management approaches. Clin Epidemiol 4:159–169.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Baron RM,
    2. Levy BD
    (2016) Recent advances in understanding and treating ARDS. F1000 Research 5:725.
    OpenUrl
  6. ↵
    1. Ware LB
    (2013) 18th Congress of Asian Pacific Society of Respirology, Biomarkers for Diagnosis, Prognosis and Clinical Trial Design in ARDS (Pacifico Yokohama, Tokyo, Japan).
  7. ↵
    1. Terpstra ML,
    2. Aman J,
    3. Amerongen GPvN,
    4. Groeneveld AJ
    (2011) Plasma biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med 39:1069–1073.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Stern D,
    2. Yan S,
    3. Yan S,
    4. Schmidt A
    (2002) Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. Adv Drug Deliv Rev 54:1615–1625.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. Buckley ST,
    2. Ehrhardt C
    (2010) The Receptor for Advanced Glycation End Products (RAGE) and the Lung. J Biomed Biotechnol 2010:917108.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Shirasawa M,
    2. Fujiwara N,
    3. Hirabayashi S,
    4. Ohno H,
    5. Iida J,
    6. Makita K,
    7. et al.
    (2004) Receptor for advanced glycation end-products is a marker of type I lung alveolar cells. Genes Cells 9:165–174.
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    1. Schmidt A,
    2. Yan S,
    3. Yan S,
    4. Stern D
    (2000) The biology of the receptor for advanced glycation end products and its ligands. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 14998:99–111.
    OpenUrl
  12. ↵
    1. Hanford L,
    2. Enghild J,
    3. Vallnickova Z,
    4. Petersen S,
    5. Schaefer L,
    6. Schaefer T
    (2004) Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE). J Biol Chem 279:50019–50024.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Uchida T,
    2. Shirasawa M,
    3. Ware L,
    4. Kojima K,
    5. Hata Y,
    6. Makita K,
    7. et al.
    (2006) Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 173:1008–10015.
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    1. Shirasawa M,
    2. Fujiwara H,
    3. Hirabayashi S,
    4. Ohno H,
    5. Iida J,
    6. Makita K,
    7. et al.
    (2004) Receptor for advanced glycation end-products is a marker of type I lung alveolar cells. Genes Cells 9:165–174.
    OpenUrlCrossRefPubMedWeb of Science
  15. ↵
    1. Cheng C,
    2. Tsuneyama K,
    3. Kominami R,
    4. Shinohara H,
    5. Sakurai S,
    6. Yonekura H
    (2005) Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs. Mod Pathol 18:1385–1389.
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    1. Geroldi D,
    2. Falcone C,
    3. Emanuele E
    (2006) Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target. Curr Med Chem 13:1971–1978.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Jabaudon M,
    2. Blondonnet R,
    3. Roszyk L,
    4. Pereira B,
    5. Guerin R,
    6. Perbet S,
    7. et al.
    (2015) Soluble forms and ligands of the receptor for advanced glycation end-products in patients with acute respiratory distress syndrome: An observational prospective study. PLoS One 10:e0135857.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Nakamura T,
    2. Stao E,
    3. Fujiwara N,
    4. Kawagoe Y,
    5. Maeda S,
    6. Yamagishi S
    (2011) Increased levels of soluble receptor for advanced glycation end products (sRAGE) and high mobility group box 1 (HMGB1) are associated with death in patients with acute respiratory distress syndrome. Clin Biochem 44:601–604.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Jabaudon M,
    2. Futier E,
    3. Roszyk L,
    4. Chalus E,
    5. Guerin R,
    6. Petit A,
    7. et al.
    (2011) Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients. Crit Care Med 39:480–488.
    OpenUrlCrossRefPubMed
    1. Calfee C,
    2. Ware L,
    3. Parsons P,
    4. Thompson B,
    5. Wickersham N,
    6. Matthay M
    (2008) Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 63:1083–1089.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Jabaudon M,
    2. Blondonnet R,
    3. Roszyk L,
    4. Bouvier D,
    5. Audard J,
    6. Clairefond G,
    7. et al.
    (2015) Soluble Receptor for Advanced Glycation End-Products Predicts Impaired Alveolar Fluid Clearance in Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 192:191–199.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Pulleritis R,
    2. Brisslert M,
    3. Jonsson I,
    4. Tarkowski A
    (2006) Soluble receptor for advanced glycation end products triggers a proinflammatory cytokine cascade via ß2 integrin Mac-1. Arthritis Rheum 54:3898–3907.
    OpenUrlCrossRefPubMedWeb of Science
  23. ↵
    1. Kamo T,
    2. Tasaka S,
    3. Tokuda Y,
    4. Suzuki S,
    5. Asakura T,
    6. Yagi K,
    7. et al.
    (2016) Levels of soluble receptor for advanced glycation end products in bronchoalveolar lavage fluid in patients with various inflammatory lung diseases. Clin Med Insights Circ Respir Pulm Med 9(Suppl 1):147–154.
    OpenUrl
  24. ↵
    1. Mrozek S,
    2. Jabaudon M,
    3. Jaber S,
    4. Paugam-Burtz C,
    5. Lefrant JY,
    6. Rouby JJ,
    7. et al.
    (2016) Elevated plasma levels of srage are associated with non-focal CT-based lung imaging in ards patients.: A prospective multicenter study. Chest 150:998–1007.
    OpenUrl
    1. Constantin JM,
    2. Futier E,
    3. Cherpenet AL,
    4. Chanques G,
    5. Guerin R,
    6. Cayot-Constantin S,
    7. et al.
    (2010) A recruitment maneuver increases oxygenation after intubation of hypoxemic intensive care unit patients: a randomized controlled study. Crit Care Med 14:R76.
    OpenUrl
    1. Jabaudon M,
    2. Blondonnet R,
    3. Lutz J,
    4. Roszyk L,
    5. Bouvier D,
    6. Guerin R,
    7. et al.
    (2016) Net alveolar fluid clearance is associated with lung morphology phenotypes in acute respiratory distress syndrome. Anaesth Crit Care Pain Med 35:81–86.
    OpenUrl
  27. ↵
    1. Malbouisson L,
    2. Muller J,
    3. Constantin J,
    4. Lu Q,
    5. Puybasset L,
    6. Rouby J
    (2001) Computed tomography assessment of positive end-expiratory pressure-induced alveolar recruitment in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 163:1444–14450.
    OpenUrlCrossRefPubMedWeb of Science
  28. ↵
    1. Gu W,
    2. Xu Z,
    3. Qi F,
    4. Sang Z,
    5. Wang C,
    6. Li F
    (2014) Plasma levels of soluble receptor for advanced glycation end products in patients with acute respiratory distress syndrome. Int J Clin Exp Med 2014:12.
    OpenUrl
  29. ↵
    1. Jabaudon M,
    2. Hamroun N,
    3. Roszyk L,
    4. Guerin R,
    5. Bazin J,
    6. Sapin V,
    7. et al.
    (2015) Effects of a recruitment maneuver on plasma levels of soluble RAGE in patients with diffuse acute respiratory distress syndrome: a prospective randomized crossover study. Intensive Care Med 41:846–855.
    OpenUrlPubMed
  30. ↵
    1. Jabaudon M,
    2. Perbet S,
    3. Pereira B,
    4. Soummer A,
    5. Roszyk L,
    6. Guerin R,
    7. et al.
    (2013) Plasma levels of sRAGE, loss of aeration and weaning failure in ICU patients: a prospective observational multicenter study. PLoS One 8:e64083.
    OpenUrl
  31. ↵
    1. Cohen J
    (2002) The immunopathogenesis of sepsis. Nature 420:885–891.
    OpenUrlCrossRefPubMedWeb of Science
  32. ↵
    1. Bouros D,
    2. Alexandrakis M,
    3. Antoniou K
    (2004) The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for Acute Respiratory Distress Syndrome. BMC Pulm Med 4:6.
    OpenUrlCrossRefPubMed
  33. ↵
    1. Mihara M,
    2. Hashizume M,
    3. Yoshida H,
    4. Suzuki M,
    5. Shiina M
    (2012) IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clin Sci (Lond) 122:143–159.
    OpenUrlCrossRefPubMed
  34. ↵
    1. Krutgen A,
    2. Rose-John S
    (2012) Interleukin-6 in sepsis and capillary leakage syndrome. Journal of Interferon &Cytokine Research 32:60–65.
    OpenUrl
  35. ↵
    1. Sadik C,
    2. Kim N,
    3. Luster A
    (2011) Neutrophils cascading their way to inflammation. Trends Immunol 32:452–460.
    OpenUrlCrossRefPubMedWeb of Science
  36. ↵
    1. Goldman JL,
    2. Sammani S,
    3. Kempf C,
    4. Saadat L,
    5. Letsiou E,
    6. Wang T,
    7. et al.
    (2014) Pleiotropic effects of interleukin-6 in a “two-hit” murine model of acute respiratory distress syndrome. Pulm Circ 4:280–288.
    OpenUrlCrossRefPubMed
  37. ↵
    1. Ware LB,
    2. Koyama T,
    3. Zhao Z,
    4. Janz DR,
    5. Wickersham N,
    6. Bernard GR,
    7. et al.
    (2013) Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome. Crit Care 17:R253.
    OpenUrlCrossRefPubMed
  38. ↵
    1. Calfee CS,
    2. Janz DR,
    3. Bernard GR,
    4. May AK,
    5. Kangelaris KN,
    6. Matthat MA,
    7. et al.
    (2015) Distinct molecular phenotypes of direct vs indirect ards in single-center and multicenter studies. Chest 147:1539–1548.
    OpenUrlCrossRefPubMed
  39. ↵
    1. Parsons P,
    2. Eisner M,
    3. Thompson B,
    4. Matthay M,
    5. Ancukiewicz M,
    6. Bernard G,
    7. et al.
    (2005) Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 33:1–6.
    OpenUrlCrossRefPubMedWeb of Science
  40. ↵
    1. Ware LB,
    2. Matthay MA,
    3. Parsons PE,
    4. Thompson BT,
    5. Januzzi JL,
    6. Eisner MD
    (2007) Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med 35:1821–1828.
    OpenUrlCrossRefPubMedWeb of Science
  41. ↵
    1. Ware LB,
    2. Koyama T,
    3. Billheimer D,
    4. Wu W,
    5. Bernard GR,
    6. Thompson T,
    7. et al.
    (2010) Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 137:288–296.
    OpenUrlCrossRefPubMedWeb of Science
  42. ↵
    1. Tseng CC,
    2. Fang WF,
    3. Leung SY,
    4. Chen HC,
    5. Chang YC,
    6. Wang CC,
    7. et al.
    (2014) Impact of serum biomarkers and clinical factors on intensive care unit mortality and 6-month outcome in relatively healthy patients with severe pneumonia and acute respiratory distress syndrome. Dis Markers 2014:804654.
    OpenUrl
  43. ↵
    1. Agrawal A,
    2. Zhuo H,
    3. Brady S,
    4. Levitt J,
    5. Steingrub J,
    6. Siegel MD,
    7. et al.
    (2012) Pathogenetic and predictive value of biomarkers in patients with ALI and lower severity of illness: results from two clinical trials. Am J Physiol Lung Cell Mol Physiol 303:L634–L639.
    OpenUrlCrossRefPubMedWeb of Science
    1. Choy E,
    2. Panayi G
    (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344:907–916.
    OpenUrlCrossRefPubMedWeb of Science
  45. ↵
    1. Grell M,
    2. Douni E,
    3. Wajant H,
    4. Lohden M,
    5. Clauss M,
    6. Maxeiner B,
    7. et al.
    (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83:793–802.
    OpenUrlCrossRefPubMedWeb of Science
  46. ↵
    1. Secher T,
    2. Vasseur V,
    3. Poisson D
    (2009) Crucial role of TNF receptors 1 and 2 in the control of polymicrobial sepsis. J Immunol 182:7855–7864.
    OpenUrlAbstract/FREE Full Text
  47. ↵
    1. Parsons PE,
    2. Matthay MA,
    3. Ware LB,
    4. Eisner MD
    (2005) Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 288:426–431.
    OpenUrlCrossRef
  48. ↵
    1. Frank JA,
    2. Parsons PE,
    3. Matthay MA
    (2006) Pathogenetic significance of biological markers of ventilator-associated lung injury in experimental and clinical studies. Chest 130:1906–1914.
    OpenUrlCrossRefPubMedWeb of Science
  49. ↵
    1. Vassalli JD,
    2. Sappino AP,
    3. Belin D
    (1991) The plasminogen activator/plasmin system. J Clin Invest 88:1067–1072.
    OpenUrlCrossRefPubMedWeb of Science
  50. ↵
    1. Sapru A,
    2. Roelofs J,
    3. Bonta P
    (2007) Plasminogen activator inhibitor type 1 is protective during severe Gram negative pneumonia. Blood 109:1593–1601.
    OpenUrlAbstract/FREE Full Text
  51. ↵
    1. Chapman H,
    2. Stone O
    (1985) A fibrinolytic inhibitor of human alveolar macrophages: induction with endotoxin. Am Rev Respir Dis 132:569–575.
    OpenUrlPubMed
  52. ↵
    1. Wang ZH,
    2. Ren WY,
    3. Zhu L,
    4. Hu LJ
    (2014) Plasminogen activator inhibitor-1 regulates lps induced inflammation in rat macrophages through autophagy activation. Scientific World Journal 2014:189168.
    OpenUrl
  53. ↵
    1. Vadasz I,
    2. Morty R,
    3. Olschewski A
    (2005) Thrombin impairs alveolar fluid clearance by promoting endocytosis of Na+,K+- ATPase. Am J Respir Cell Mol Biol 33:343–354.
    OpenUrlCrossRefPubMedWeb of Science
  54. ↵
    1. Fujishima S
    (2014) Pathophysiology and biomarkers of acute respiratory distress syndrome. J Intensive Care 2:32.
    OpenUrl
  55. ↵
    1. Blondonnet R,
    2. Constantin JM,
    3. Sapin V,
    4. Jabaudon M
    (2016) A Pathophysiologic Approach to Biomarkers in Acute Respiratory Distress Syndrome. Dis Markers 2016:3501373.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section